|

货币单位:美元(USD)

Aegerion制药

Aegerion Pharmaceuticals, Inc. (aegr)

实时(?):

盘后(?):

读取中...

-- (--%)

开盘价:--	最高价:--	最低价:--	52周最高价:--	52周最低价:--
成交量:--	平均成交量:--	市值:--	市盈率:--	预期市盈率:--
每股收益:--	贝塔系数:--	股息:--	收益率:--	总股本:--

提示:交易结束

Sheila M. Frame	Sheila M. Frame is currently the President & Director at Aegerion Pharmaceuticals, Inc. and Vice President & Head-Biopharmaceuticals at Sandoz, Inc. She previously worked as Vice President-Public Affairs at AstraZeneca Canada, Inc. from 1999 to 2007. She also held positions at Bristol-Myers Squibb Canada Co. and Amryt Pharma Holdings Ltd. as well as serving as an Independent Director at Theratechnologies, Inc. from 2019 to 2021. Ms. Frame received an undergraduate degree from York University and an MBA from Concordia University.

Sheila M. Frame

Sheila M. Frame is currently the President & Director at Aegerion Pharmaceuticals, Inc. and Vice President & Head-Biopharmaceuticals at Sandoz, Inc. She previously worked as Vice President-Public Affairs at AstraZeneca Canada, Inc. from 1999 to 2007. She also held positions at Bristol-Myers Squibb Canada Co. and Amryt Pharma Holdings Ltd. as well as serving as an Independent Director at Theratechnologies, Inc. from 2019 to 2021. Ms. Frame received an undergraduate degree from York University and an MBA from Concordia University.